Eptifibatide side effects by duration, gender and age - a phase IV clinical study of FDA data
Side effects are reported by people who take Eptifibatide. Common side effects include acute myocardial infarction among females, and thrombocytopenia among males.
The phase IV clinical study is created by eHealthMe based on 676 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
676 people who take Eptifibatide and have side effects are studied.
What is Eptifibatide?
Eptifibatide has active ingredients of eptifibatide. Currently, eHealthMe is studying from 676 Eptifibatide users.
Number of Eptifibatide reports submitted per year:
Eptifibatide side effects by time on the drug *:
Eptifibatide side effects by gender *:
Eptifibatide side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Eptifibatide?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on eptifibatide (the active ingredients of Eptifibatide) and Eptifibatide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Alternative drugs to, pros and cons of Eptifibatide:
- Eptifibatide (676 reports)
Common Eptifibatide side effects:
- Thrombocytopenia (decrease of platelets in blood): 116 reports
All Eptifibatide side effects from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Aspirin and Toxic Shock Syndrome - 6 seconds ago
- Avonex and Tubal Ligation - 21 seconds ago
- Isosorbide Mononitrate and Coenzyme Q10 drug interaction - 32 seconds ago
- Aspirin and Collagen Disorder - a minute ago
- Copegus and Anaemia - a minute ago
- Zevalin and Chlor-Trimeton drug interaction - 2 minutes ago
- Buspar and Monistat 7 drug interaction - 2 minutes ago
- Mitomycin and Leukopenia - 2 minutes ago
- Polaramine and Zevalin drug interaction - 2 minutes ago
- Wellbutrin Xl and Invega Sustenna drug interaction - 2 minutes ago